TARA TYE: Open Payments
NPI 1093340630 · TULLAHOMA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 27 payments from 11 companies in 2025. Trend: 2023 $614 · 2024 $687 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $144 |
| Lilly USA, LLC | 4 | $66 |
| PFIZER INC. | 2 | $44 |
| Novo Nordisk Inc | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Amgen Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: MOUNJARO, VRAYLAR, QULIPTA, CAPLYTA, UBRELVY, TRELEGY ELLIPTA, PREVNAR 20, NURTEC ODT.
Industry payments across TN — which companies pay providers there.
